Supplement

CME/CE Questions

Published Online: April 01, 2007
  1. patients with chronic conditions did not contribute substantially to costs
  2. older employees were responsible for most costs
  3. costs were associated with a lack of adherence to pharmacotherapy
  4. no factors could be identified to explain the high costs

17. When Pitney Bowes moved medications for chronic conditions to the lowest (least expensive) tier of the pharmacy benefit plan __________.

  1. diabetes-related emergency department and disability rates decreased
  2. total pharmacy costs per person dropped dramatically
  3. adherence to diabetic medications was not affected
  4. the average employee health cost was reduced by half

18. There is a strong connection between copayments, adherence to therapy, and improved patient outcomes.

     Do not agree                Strongly agree

     1         2         3         4         5         6

19. Newer agents need to be considered earlier in the management of diabetic patients with poor glycemic control.

     Do not agree                Strongly agree

     1         2         3         4         5         6

20. Results from the Pitney Bowes benefits design model have shown that novel benefit designs are necessary to improve health outcomes in patients with chronic diseases.

     Do not agree                Strongly agree

     1         2         3         4         5         6










Issue: Improving Members’ Outcomes Across the Continuum of Diabetes: Assessing the Impact of New Measures, Technologies, and Benefit Design Strategies
More on AJMC.COM